D2M Biotherapeutics is a startup biotech company located at Natick, MA. D2M (Data to Medicine) is a human-genetics driven biotherapeutics discovery company with a focus on immuno-oncology and inflammatory diseases. D2M has built up a platform of novel target discovery via deep mining the unprecedented disease genomic data. D2M is building up a sharply focused pipeline of monoclonal antibody or protein therapeutics targeting human genetics validated immune pathways. D2M's immediate focus is creating novel classes of biologics on cancers beyond anti-PD1/L1 IO therapies and rare immunology diseases currently with limited therapeutic options.
